Keywords: gilead, begins, enrolling, into, ph, ii, trial

Gilead begins enrolling into Ph II trial of cicletanine

Article | 30 March 2009

Print This

US drugmaker Gilead Sciences has begun enrolling patients in a Phase II trial of cicletanine HCl, an oral agent in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in